Market News AIOpen the app

PharmaCyte Biotech signed an important deal with Q/C Technologies to swap warrants for shares and change a stock deadline.

DealRead the original at SEC EDGAR
Neutral

PharmaCyte traded Q/C warrants for Q/C shares without paying cash, but agreed to delay the due date on Q/C preferred shares by 6 months. These changes reshape its holdings, with no clear change to its business outlook.

PMCB · PharmaCyte Biotech, Inc.

AI read · Neutral

The AI's read

This changes what PharmaCyte holds, but the filing does not show a clear change to its business outlook. The Q/C shares were sized using the calculated value of the warrants, and PharmaCyte paid no cash.

Get alerts for PMCB

Follow PharmaCyte Biotech, Inc. (PMCB) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PMCB
Free on the App Store and Google Play, or on the web.